1 To unpack these findings, Pharmaceutical Commerce spoke to Philip Sclafani, a partner at PwC and key advisor to the report
Other potential risks include: Gastrointestinal adverse effects nausea, vomiting, and diarrhoea are recognised class effects of GLP-1 receptor agonists (as documented in the Wegovy [semaglutide] Summary of Product Characteristics [SmPC] available via the electronic Medicines Compendium [emc])
Avoid Harsh Skincare Products Temporarily Refrain from using strong exfoliators, retinoids, peels, or chemical treatments for a few days
However, this frequency declines as they reach their objectives
If youre a self-funded employer, you have more options than those stuck in fully insured plans
The Role of Clinical Assessment All IV services begin with a clinical assessment to determine appropriateness, safety, and individualized care planning